Abstract
A glycosaminoglycan polysulfate ester, L-1016, was administered intra-articularly over a period of six-weeks to selected horses with joint disorders which demonstrated by synovial fluid analysis lesions and/or degeneration of the articular cartilage and impairment of synovial membrane function. Over the course of treatment, significant changes in synovial fluid viscosity and protein were observed. In general, these laboratory data were reflected directly in clinical observations. Response to the treatment was characterized by decreases in outward signs of swelling, increases in flexion and lessening of lameness.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
